- ICICI Prudential’s net income for the second quarter is 2.52 billion rupees, surpassing the estimated 2.19 billion rupees.
- Net premium income for the same period stands at 107.54 billion rupees.
- For the first half of the year, the value of new business is 10.58 billion rupees.
- The annual premium equivalent during the first half is 44.67 billion rupees.
- The value of new business increased by 4.2% compared to the previous period.
- Analyst recommendations for ICICI Prudential include 18 buys, 12 holds, and 3 sells.
“`
A look at ICICI Prudential Life Insurance Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
ICICI Prudential Life Insurance, a leading provider of life insurance services in India, has garnered favorable Smart Scores across various key factors. With a solid Growth score of 4 and a strong Momentum score of 4, the company shows promising potential for long-term expansion and market performance. This indicates a positive outlook for the company’s future growth trajectory.
Furthermore, ICICI Prudential Life Insurance demonstrates a good level of Resilience and Value with scores of 3 and 2 respectively. These scores suggest that the company is well-positioned to withstand potential challenges and offers investment value. While the Dividend score is moderate at 2, the overall Smart Scores paint a optimistic picture of ICICI Prudential Life Insurance‘s long-term prospects in the life insurance sector.
Summary: ICICI Prudential Life Insurance Company Limited of India provides life insurance services. The company offers claim processing, electronic insurance accounts, and other services. ICICI Prudential Life Insurance conducts its business in India.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
